This chapter describes cell-type specific aptamers and their use in diagnostics and therapy. Aptamers are single-stranded oligo(deoxy)nucleotides that selectively bind to their target molecules with high affinity. Cell-type specific aptamers in particular can be identified via SELEX using isolated surface proteins or whole cells as targets.Cell-type specific aptamers have been mostly selected targeting cancer cells, which essentially take into account that about 20 % of the deaths worldwide are due to cancer and cancer-related diseases. In the early stages of cancer, circulating cancer cells are very rare. Cancer cell-targeting aptamers allow the identification of these rare circulating cells, thereby providing new tools for early cancer detection and diagnosis. Furthermore, they can be easily synthesized with a variety of modifications. In this regard tumor cell-targeting aptamers are employed as potential delivery vehicles, whereas they are equipped with various cargo molecules, such as toxins, chemotherapeutics, or siRNA molecules, that allow for the development of cell-specific treatment regimens and the decrease of unwanted side effects. Contents
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.